Skip to content

Medicine Man Technologies, Inc.: 10-Q filed 2020-11-16

What Medicine Man Technologies, Inc. reported in its quarterly report filed 2020-11-16 (fiscal Q3 2020): 42 published measures, 112 facts as tagged in accession 0001683168-20-003969.

This filing

Form
10-Q (quarterly report)
Filed
2020-11-16
Fiscal period
fiscal Q3 2020
Accession
0001683168-20-003969 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Medicine Man Technologies, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-09-3032,696,633USD
At 2019-12-3132,228,607USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-09-306,978,300USD
At 2019-12-315,648,662USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-09-3025,718,333USD
At 2020-06-3027,511,058USD
At 2019-12-3126,579,945USD
At 2019-09-3027,939,841USD
At 2019-06-3013,626,948USD
At 2018-12-3117,073,764USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2020-09-302,981,688USD
At 2019-12-3111,853,627USD
At 2019-09-3015,204,587USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-2,914,211USD92
2020-01-01 to 2020-09-30-10,889,228USD274
2019-07-01 to 2019-09-30-1,827,978USD92
2019-01-01 to 2019-09-30-13,562,446USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-6,303,992USD274
2019-01-01 to 2019-09-30-4,679,562USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2020-01-01 to 2020-09-30976,685USD274
2019-01-01 to 2019-09-307,312USD273

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2020-07-01 to 2020-09-307,430,374USD92
2020-01-01 to 2020-09-3016,057,837USD274
2019-07-01 to 2019-09-305,338,869USD92
2019-01-01 to 2019-09-309,100,164USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2020-01-01 to 2020-09-3042,000USD274
2019-01-01 to 2019-09-3020,201,726USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-3,107,900USD274
2019-01-01 to 2019-09-30-639,365USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-09-30-33,705,705USD
At 2019-12-31-22,816,477USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2020-09-302,719,154USD
At 2019-12-31239,078USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2020-07-01 to 2020-09-301,453,986USD92
2020-01-01 to 2020-09-305,815,808USD274
2019-07-01 to 2019-09-30940,870USD92
2019-01-01 to 2019-09-303,166,276USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-3,618,826USD92
2020-01-01 to 2020-09-30-14,079,861USD274
2019-07-01 to 2019-09-30-925,607USD92
2019-01-01 to 2019-09-30-11,496,504USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-09-306,575,953USD
At 2019-12-3115,569,115USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-09-305,294,295USD
At 2019-12-315,581,859USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2020-09-302,957,390USD
At 2019-12-31699,961USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2020-09-3017,445,843USD
At 2019-12-3112,304,306USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2020-09-3070,329USD
At 2019-12-3175,289USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2020-09-30812,212USD
At 2019-12-31313,317USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2020-07-01 to 2020-09-306,400,290USD92
2020-01-01 to 2020-09-3020,233,567USD274
2019-07-01 to 2019-09-303,478,232USD92
2019-01-01 to 2019-09-3015,125,299USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2020-09-302,151,612USD
At 2019-12-31684,940USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2020-07-01 to 2020-09-302,781,464USD92
2020-01-01 to 2020-09-306,153,706USD274
2019-07-01 to 2019-09-302,552,625USD92
2019-01-01 to 2019-09-303,628,795USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2020-07-01 to 2020-09-304,648,910USD92
2020-01-01 to 2020-09-309,904,131USD274
2019-07-01 to 2019-09-302,786,244USD92
2019-01-01 to 2019-09-305,471,369USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2020-07-01 to 2020-09-301,298,693USD92
2020-01-01 to 2020-09-303,054,091USD274
2019-07-01 to 2019-09-30718,990USD92
2019-01-01 to 2019-09-301,092,702USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-09-3041,762,146shares
At 2019-12-3139,952,628shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2020-09-3060,714,343USD
At 2019-12-3150,356,469USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2020-09-301,650,117USD
At 2019-12-3159,943USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2020-09-301,684,005USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2020-09-303,613,118USD
At 2019-12-31398,432USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2020-09-30893,964USD
At 2019-12-31159,354USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2020-09-30127,999USD
At 2019-12-310USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2020-09-301,426,315USD
At 2019-12-311,091,204USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2020-09-30254,602USD
At 2019-12-31529,416USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-2,914,211USD92
2020-01-01 to 2020-09-30-10,889,228USD274
2019-07-01 to 2019-09-30-1,827,978USD92
2019-01-01 to 2019-09-30-13,562,446USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2020-07-01 to 2020-09-30226,358USD92
2020-01-01 to 2020-09-30317,332USD274
2019-07-01 to 2019-09-3015,264USD92
2019-01-01 to 2019-09-3040,881USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2020-01-01 to 2020-09-30322,292USD274
2019-01-01 to 2019-09-3045,768USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2020-07-01 to 2020-09-301,665USD92
2020-01-01 to 2020-09-304,960USD274
2019-07-01 to 2019-09-301,730USD92
2019-01-01 to 2019-09-305,155USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2020-07-01 to 2020-09-30704,615USD92
2020-01-01 to 2020-09-303,190,633USD274
2019-07-01 to 2019-09-30-902,371USD92
2019-01-01 to 2019-09-30-2,065,942USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2020-01-01 to 2020-09-3042,000USD274
2019-01-01 to 2019-09-3019,600,000USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-1,292,509USD274
2019-01-01 to 2019-09-302,868,093USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-271,305USD274
2019-01-01 to 2019-09-30-81,530USD273

Inspect the source

Entity
Medicine Man Technologies, Inc. / CIK 0001622879
Captured
SEC response SHA-256
1261bd7a9caa81b103d72d0d0ab2acc4054c1fb2aa448834ecbc9bb252b5bd72

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001622879.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))